Skip to main content
Tempest Therapeutics, Inc. logo

Tempest Therapeutics, Inc. — Investor Relations & Filings

Ticker · TPST ISIN · US69014Q1013 US Professional, scientific and technical activities
Open in API
Filings indexed 986 across all filing types
Latest filing 2013-09-11 Regulatory Filings
Country US United States of America
Listing US TPST

About Tempest Therapeutics, Inc.

https://www.tempesttx.com/

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates and cell therapies. The company develops first-in-class therapeutics that combine tumor-targeted and immune-mediated mechanisms to treat cancer. Its lead product candidate is amezalpat (TPST-1120), an oral, selective PPARα antagonist being evaluated in a global, randomized combination study for hepatocellular carcinoma. In addition to its small molecule platform, the company is also developing dual-chimeric antigen receptor (CAR) T-cell programs.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce unscheduled material events or corporate changes. The text indicates it is a short filing (2562 characters) reporting an attached press release as Exhibit 99.1. There is no substantive financial data or detailed report content within the document itself. It is primarily an announcement of an event or press release rather than a full financial report or detailed filing. According to the rules, such short filings that announce or attach other documents without containing the report itself should be classified as Regulatory Filings (RNS).
2013-09-11 English
POS AM
Transaction in Own Shares Classification · 95% confidence The document is a Post-Effective Amendment No. 1 to a Registration Statement on Form S-1 converted to Form S-3 filed with the SEC. It includes a prospectus related to the resale of shares by selling stockholders, details about the offering, risk factors, and company overview. The document is a registration statement amendment related to securities offering and resale, not a financial report, earnings release, or management discussion. It is a capital markets filing related to share registration and resale, which fits the category of Transaction in Own Shares (POS) as it involves registration of shares for resale by selling stockholders. The document length is substantial and contains detailed offering information, not just an announcement or certification. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2013-08-30 English
POS AM
Capital/Financing Update Classification · 100% confidence The document is a Post-Effective Amendment No. 2 to a Form S-1 registration statement filed with the SEC, converting the Form S-1 into a Form S-3 registration statement. It includes a prospectus related to the offering and resale of shares by selling stockholders. The content focuses on securities registration, offering details, and related disclosures. This type of filing is related to capital raising and securities registration activities, which aligns with Capital/Financing Update filings. It is not an earnings release, annual report, or other financial report, but a regulatory filing related to securities offering and registration. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2013-08-30 English
S-3
Capital/Financing Update Classification · 100% confidence The document is a Form S-3 Registration Statement filed with the SEC under the Securities Act of 1933. It is a registration statement for securities offerings, describing the types of securities to be registered and the general terms of the offering. It includes details about the registration fee, the types of securities (common stock, preferred stock, debt securities, warrants, rights, purchase contracts, units), and the shelf registration process allowing offerings up to $100 million. The document is not a financial report, earnings release, or management discussion, but rather a capital markets filing related to securities registration and offering. Therefore, it fits the category of Capital/Financing Update (CAP).
2013-08-30 English
Regulatory Filings 2013
Regulatory Filings
2013-08-30 English
424B3
Interim / Quarterly Report Classification · 100% confidence The document is a Form 10-Q quarterly report filed with the SEC for the quarterly period ended June 30, 2013. It contains detailed unaudited financial statements including balance sheets, statements of operations, cash flows, and notes to the financial statements. It also includes management's discussion and analysis, risk factors, and other required disclosures typical of a quarterly report. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement or certification. The presence of the Form 10-Q header and the detailed financial data confirms this classification.
2013-08-13 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.